Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase
- Bioorg Med Chem Lett. 2005 Aug 1;15(15):3519-23. doi: 10.1016/j.bmcl.2005.05.096.
Affiliations
- 1. GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC 27709, USA. [email protected]
PMID: 15990302
DOI: 10.1016/j.bmcl.2005.05.096
Abstract
A series of dianilinopyrimidineureas demonstrate potency as VEGFR2 kinase inhibitors.
Products